Search clinical trials for: hLL2 (Epratuzumab)
Total 343 results
-
Gilead SciencesCompleted
-
National Institute of Arthritis and Musculoskeletal...Completed
-
Gilead SciencesTerminated
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
Gilead SciencesTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Nantes University HospitalGilead Sciences; Institut Cancerologie de l'OuestWithdrawnLymphocyte B CD22 Positive Acute Lymphoblastic Leukemia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 PositiveUnited States
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
French Innovative Leukemia OrganisationTerminated
-
Nantes University HospitalWithdrawnCD22+ Relapsed/Refractory B-ALLFrance
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
Nantes University HospitalUnknown
-
Gilead SciencesCompletedChronic Lymphocytic LymphomaUnited States
-
UCB Biopharma S.P.R.L.Pharmaceutical Research Associates; Richmond Pharmacology Limited; Eurofins; ACM... and other collaboratorsCompletedSystemic Lupus ErythematosusUnited Kingdom
-
Charite University, Berlin, GermanyEuropean Organisation for Research and Treatment of Cancer - EORTC; Centre... and other collaboratorsCompletedAcute Lymphoblastic Leukemia (ALL)United Kingdom, Norway, Germany, Italy, France, Belgium, Denmark, Australia, Austria, Czechia, Finland, Israel, Japan, Netherlands, Poland, Portugal, Switzerland
-
Weill Medical College of Cornell UniversityGilead SciencesCompletedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
UCB PharmaTerminatedLupus Erythematosus, SystemicUnited States
-
UCB PharmaTerminatedSystemic Lupus ErythematosusUnited States, Belgium, Netherlands, United Kingdom, Spain, Hungary
-
Gilead SciencesTerminatedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
AmgenCompletedNon-Hodgkin's Lymphoma
-
Kaplan Medical CenterGilead SciencesUnknownChronic Lymphocytic LeukemiaIsrael
-
Gilead SciencesCompletedLymphoma, B-Cell | Non-Hodgkin's Lymphoma
-
Centre Hospitalier Universitaire de Pointe-a-PitreDirection Générale de l'Offre de SoinsRecruitingDyslipidemia | Sickle Cell Disease | ComplicationFrance
-
Gilead SciencesCompletedMultiple Myeloma | Myeloma, Plasma-Cell | PLASMACYTOMAUnited States
-
Gilead SciencesUnknownLymphomaSwitzerland, United States, Italy, Sweden, Austria
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Gilead SciencesUnknownLymphomaSwitzerland, United States, Italy, Sweden, Austria
-
Shanghai Henlius BiotechCompletedHealthy Male VolunteersChina
-
Queen Mary University of LondonGilead SciencesUnknownRecurrent or Refractory B Cell Acute Lymphoblastic LeukaemiaUnited Kingdom
-
Zydus Lifesciences LimitedNot yet recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Shengjing HospitalNot yet recruiting
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedElderly Metastatic Breast Cancer PopulationBelgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
Garden State Cancer Center at the Center for Molecular...Unknown
-
UCB PharmaWithdrawnSystemic Lupus ErythematosusUnited States, France, United Kingdom, Spain, Belgium, Netherlands, Canada, Brazil, Germany, Hungary, Czech Republic, Italy, Slovakia
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
-
Genentech, Inc.Completed
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
-
BiocadRecruitingBreast CancerRussian Federation
-
Ontario Clinical Oncology Group (OCOG)Terminated
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Brazil, Canada, France, Germany, Hungary, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom, Australia, Belgium, Bulgaria, Czechia, Estonia, Israel, Korea, Republic of, T... and more
-
Gilead SciencesTerminatedMultiple MyelomaUnited States
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
UCB PharmaCompleted
-
BiocadActive, not recruiting
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Genentech, Inc.Completed
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Australia, Belgium, Brazil, Bulgaria, Czechia, Estonia, France, Germany, India, Israel, Italy, Korea, Republic of, Lithuania, Mexico, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom